期刊文献+

DLL4、COX-2和MMP-2在乳腺癌组织中的表达及临床意义 被引量:5

Expressions of DLL4,COX-2 and MMP-2 in breast cancer tissues and its significance
下载PDF
导出
摘要 目的探讨Delta样配体4(DLL4)、环氧合酶-2(COX-2)和基质金属蛋白酶-2(MMP-2)在不同乳腺癌分子亚型组织中的表达情况及意义。方法采用免疫组化SP法检测乳腺癌(Luminal A型41例,Luminal B型18例,HER-2过表达型22例,基底细胞样型19例)组织100例及癌旁组织40例中DLL4、COX-2和MMP-2的表达情况,并分析三者表达及与淋巴结转移的相关性。结果 DLL4、COX-2和MMP-2在乳腺癌组织中的阳性表达率分别为73.0%、81.0%和93.0%,均明显高于癌旁组织(P<0.05)。在不同分子亚型乳腺癌组织中,DLL4、COX-2和MMP-2在HER-2过表达型乳腺癌组织中的阳性表达率分别为95.5%、100.0%和100.0%,在基底细胞样型乳腺癌组织中分别为89.5%、94.7%和100.0%,均高于Luminal A型和Luminal B型乳腺癌组织(P<0.05)。DLL4、COX-2和MMP-2在有淋巴结转移的乳腺癌组织中阳性表达率分别为88.7%、92.5%和96.2%,显著高于无淋巴结转移者的阳性表达率(P<0.05)。DLL4分别与COX-2、MMP-2表达呈正相关(r=0.215,P<0.05;r=0.435,P<0.05)。结论 DLL4、COX-2和MMP-2在基底细胞样型和HER-2过表达型乳腺癌组织中呈高表达,DLL4、COX-2和MMP-2共同参与乳腺癌的发生、发展及浸润转移,联合检测三者表达可评估乳腺癌的转移情况。 Objective To study the expressions of DLIA ( delta-like ligand 4) , COX-2 ( Cyclooxygenase-2 ) and MMP-2 ( ma- trix metalloproteinase-2) in different molecular subtypes of breast cancer and analyze their correlation. Methods The expressions of DLL4, COX-2 and MMP-2 were determined by SP immunohistochemistry in 100 cases of breast carcinoma (41 luminal A, 18 lumianl B, 22 HER-2 over-expression and 19 basal-like subtypes) and 40 cases of adjacent normal breast tissues. Then the correlation of DLL4, COX-2 and MMP-2 expression with lymph node metastasis was analyzed. Results The positive expression rates of DLIA, COX-2 and MMP-2 in breast cancer were 73.0% , 81.0% and 93.0% , significantly higher than those in adjacent normal breast tis- sues(P〈0. 05). The positive rates of DLL4, COX-2 and MMP-2 were 95.5%, 100. 0% and 100. 0% in HER-2 over-expression type, and 89.5% , 94. 7% and 100. 0% in basal-like subtype. They were significantly higher than those in luminal A and lmninal B subtypes(P 〈 0. 05). The expression of DLIA, COX-2 and MMP-2 in lymph node metastasis group were 88.7% , 92.5% and 96.2% respectively, higher than those without lymph node metastasis group( P 〈 0. 05 ). Positive correlation could be found between DLIA and COX-2, MMP-2 expression(r=0.215, P〈0.05; r=0.435, P〈0.05). Conclusion DLL4, COX-2 and MMP-2 are highly ex- pressed in HER-2 over-expression and basal-like subtypes of breast cancer. These results suggest that they might be important factors in breast carcinogenesis, development and metastasis. These proteins are indicators of metastasis of breast cancer.
出处 《临床肿瘤学杂志》 CAS 2012年第9期814-817,共4页 Chinese Clinical Oncology
关键词 Delta样配体4 环氧合酶-2 基质金属蛋白酶-2 乳腺癌 分子亚型 DLIA COX-2 MMP-2 Breast cancer Molecular subtype
  • 相关文献

参考文献19

  • 1Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the carolina breast cancer study [ J]. JAMA, 2006, 295(21 ):2492-2502.
  • 2Patel NS, Li JL, Generali D. et al. Up-regulation of delta-like 4 ligand in human tumor vaseulature and the role of basal expression in endothelial cell function [ J ]. Cancer Res, 2005, 65 (19) :8690 -8697.
  • 3Yu L,Wu WK, Li ZJ,et al. Enhancement of doxorubicin cytotoxicity on hunmn esophageal squamous cell carcinoma cells by indomethacinand4- [ 5- ( 4-Chlorophenyl ) -1 H-Pyrazol-1 -yl ] benzenesul-fonamidc ( SC236 ) via inhibiting P-glycoprotein activity [ J ].Mol Pharmacol,2009,75 (6) : 1364 - 1373.
  • 4Peihong S, Perry F. Expression of nni23, MMP-2, TIMP-2 in breast neoplasm[ J]. Ethiop Med J,2007,45 ( 1 ) :78 - 83.
  • 5Kopfstein L, Christofori G. Metastasis cell-autonomous mechanisms versus contributions by the tumor microenviroment [ J ]. Cell Mol Life Sci, 2006, 63 (4) : 449 -468.
  • 6Joyce JA. Therapeutic targeting of the tumor microenvironment [J]. Cancer Cell, 2005, 7(6) : 513 -520.
  • 7Kerbel RS. Tumor angiogenesis[J]. N Engl J Med, 2008, 358 (19) 2039 -2049.
  • 8Thurston G,Noguera-Troise I,Yancopoulos GD. The Delta paradox:The Delta paradox-DLIA blockade leads to more tumour vessels but less tumour growth [ J]. Nat Rev Cancer,2007, 7 (5) : 327 - 331.
  • 9Benedito R, Ttindade A, Hirashima M, et al. Loss of Notch signalling induced by DLIA causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli [ J ]. BMC Dev Biol,2008, 8(16) : 117.
  • 10Li JL, Sainson RC, Shi W, et al. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo[J]. Cancer Res, 2007,67 (23) : 11244 - 11253.

二级参考文献14

共引文献27

同被引文献50

  • 1于琦.肿瘤-睾丸抗原在乳腺癌中的研究现状[J].肿瘤防治研究,2014,41(2):173-175. 被引量:6
  • 2魏爱英,张庆柱,张捷.多西他赛诱导乳腺癌Bcap37细胞凋亡作用的研究[J].中华肿瘤防治杂志,2006,13(18):1384-1386. 被引量:10
  • 3Turpeenniem I , Hujanen T. Gelatinases ( MMP - 2 and - 9) and their natural inhibitors as prognostic indicators in solid cancers [J]. Biochimie, 2005, 87 (324):287-297.
  • 4Sun J, Hemler ME. Regulation of MMP - 1 and MMP - 2 pro- duction through CD147/extracellular matrix metalloproteinaseinducer interactions [ J ] . Cancer Res, 2001, 61 (5) : 2276 - 2281.
  • 5Smith WL,Langenbach R.Why there are two cyclooxygenase isozymes [J].J Clin Invest,2001,107:1491-1495.
  • 6Bartek J,Iggo R,Caannon J,et al.Genetic and immuno-chemical analysis of mutant p53 in human breast cancer cell lines [J].Oncogene,1990,5(6):893-899.
  • 7Patel NS,Li JL,Generali D. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function[J].Cancer Research,2005,(19):8690-8697.doi:10.1158/0008-5472.CAN-05-1208.
  • 8Benedito R,Trindade A,Hirashima M. Loss of notch signalling induced by Dl14 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli[J].BMC Development Biology,2008,(16):117.
  • 9Li JL,Sainson RC,Shi W. Delta-like 4 Notch ligand regulates tumor angiogenesis,improves tumor vascular function,and promotes tumor growth in vivo[J].Cancer Research,2007,(23):11244-11253.
  • 10Shin S,Sung BJ,Cho YS. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7[J].Biochemistry,2001,(04):1117-1123.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部